title: Regular ingestion of tea does not inhibit in vivo lipid peroxidation in humans.
abstract: Prospective studies suggest that tea may protect against cardiovascular disease. A potential mechanism for such an effect involves inhibition of lipid peroxidation by polyphenolic antioxidants derived from tea. Our objective was to determine whether regular ingestion of tea could inhibit in vivo lipid peroxidation. Two controlled intervention studies assessed the effects of regular ingestion of tea on lipid peroxidation determined by measurement of urinary F(2)-isoprostane excretion. Study 1: The effects of 1000 mL/d of green tea and black tea were compared with hot water containing caffeine in 13 subjects with elevated blood pressure using a randomized 3-period (7 d each) crossover design. Study 2: The effects of 1250 mL/d of black tea were compared with hot water in 22 subjects with mildly raised serum total cholesterol concentrations using a randomized 2-period (4 wk each) crossover design. F(2)-isoprostane excretion was not altered after regular ingestion of green tea (273 +/- 48 pmol/mmol creatinine) or black tea (274 +/- 39 pmol/mmol creatinine) in comparison with hot water (263 +/- 47 pmol/mmol creatinine; Study 1), or by regular ingestion of black tea (334 +/- 71 pmol/mmol creatinine) in comparison with hot water (355 +/- 75 pmol/mmol creatinine; Study 2). These results do not support the suggestion that polyphenolic antioxidants derived from tea inhibit in vivo lipid peroxidation.
authors.affiliation: University of Western Australia, Department of Medicine and HeartSearch, Royal Perth Hospital, Perth, WA 6001, Australia. jonathan@cyllene.uwa.edu.au
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Hodgson
authors.forename: Kevin D
authors.initials: KD
authors.lastname: Croft
authors.forename: Trevor A
authors.initials: TA
authors.lastname: Mori
authors.forename: Valerie
authors.initials: V
authors.lastname: Burke
authors.forename: Lawrence J
authors.initials: LJ
authors.lastname: Beilin
authors.forename: Ian B
authors.initials: IB
authors.lastname: Puddey
mesh_terms: D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000494:pharmacology; D003404:Creatinine / Q000652:urine; D018592:Cross-Over Studies; D028441:F2-Isoprostanes / Q000652:urine*; D005260:Female; D005419:Flavonoids; D005707:Gallic Acid / Q000031:analogs & derivatives* / Q000652:urine; D006801:Humans; D015227:Lipid Peroxidation / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D018384:Oxidative Stress; D010636:Phenols / Q000494:pharmacology*; D010936:Plant Extracts / Q000494:pharmacology*; D011108:Polymers / Q000494:pharmacology*; D059808:Polyphenols; D013662:Tea / Q000737:chemistry*
chemical_list: D000975:Antioxidants; D028441:F2-Isoprostanes; D005419:Flavonoids; D010636:Phenols; D010936:Plant Extracts; D011108:Polymers; D059808:Polyphenols; D013662:Tea; C024272:3,5-dihydroxy-4-methoxybenzoic acid; D005707:Gallic Acid; D003404:Creatinine